Pseudomonas syringae pv. actinidiae (Psa) which causes bacterial canker of kiwifruit (Actinidia deliciosa and A. chinensis) was first isolated in Japan in 1984 (Takikawa et al., 1989), and soon after in Korea (Koh et al., 1994) and Italy (Scortichini, 1994). The economic impact on the global production of kiwifruit of those early occurrences was relatively limited (Vanneste et al., 2011). However, the latest outbreak of Psa which started in Italy in 2008 and rapidly spread throughout most of the kiwifruit growing regions of the world, represents a major threat to the global kiwifruit industry (Vanneste, 2012). The pathovar actinidiae is not a genetically homogeneous pathovar; strains can be grouped in four biovars based on their molecular, microbiological and pathogenic characteristics (Vanneste et al., 2013) which is consistent with MLST and whole genome sequence analysis (Ferrante and Scortichini, 2010; Mazzaglia et al., 2011; Chapman et al., 2012). The recent outbreak of bacterial canker on kiwifruit in Europe and New Zealand is caused by the same biovar of Psa (biovar 3) (Chapman et al., 2012; Vanneste et al., 2013). During the 2 years that the pathogen has been present in New Zealand, over 60% of the area planted in kiwifruit has been affected (Kiwifruit Vine Health, 2012). This rapid spread may be attributable to the virulence of biovar 3 and to the scarcity of products available for control of plant pathogenic bacteria in general, and Psa in particular. Many products used for control of plant pathogenic bacteria contain antibiotics (mostly streptomycin) or heavy metals (mostly copper). Both types of products do have limitations because of phytotoxicity or because they are not authorized in some countries (e.g., antibiotics in Europe). This has led to a large screening programme in New Zealand for the identification of potentially effective products to control Psa. The products tested included a number of commercially available potential elicitors of host resistance. One of the most effective elicitors in glasshouse trials on A. chinensis and A. deliciosa was acibenzolar-S-methyl [ASM], sold under the names of Bion® or Actigard® (Syngenta).
Tony Reglinski, Joel L. Vanneste, Kirstin Wurms, Elaine Gould, Francesco Spinelli, Erik Rikkerink (2013). Using fundamental knowledge of induced resistance to develop control strategies for bacterial canker of kiwifruit caused by Pseudomonas syringae pv. actinidiae. FRONTIERS IN PLANT SCIENCE, 4(1), 1-4 [10.3389/fpls.2013.00024].
Using fundamental knowledge of induced resistance to develop control strategies for bacterial canker of kiwifruit caused by Pseudomonas syringae pv. actinidiae
SPINELLI, FRANCESCO;
2013
Abstract
Pseudomonas syringae pv. actinidiae (Psa) which causes bacterial canker of kiwifruit (Actinidia deliciosa and A. chinensis) was first isolated in Japan in 1984 (Takikawa et al., 1989), and soon after in Korea (Koh et al., 1994) and Italy (Scortichini, 1994). The economic impact on the global production of kiwifruit of those early occurrences was relatively limited (Vanneste et al., 2011). However, the latest outbreak of Psa which started in Italy in 2008 and rapidly spread throughout most of the kiwifruit growing regions of the world, represents a major threat to the global kiwifruit industry (Vanneste, 2012). The pathovar actinidiae is not a genetically homogeneous pathovar; strains can be grouped in four biovars based on their molecular, microbiological and pathogenic characteristics (Vanneste et al., 2013) which is consistent with MLST and whole genome sequence analysis (Ferrante and Scortichini, 2010; Mazzaglia et al., 2011; Chapman et al., 2012). The recent outbreak of bacterial canker on kiwifruit in Europe and New Zealand is caused by the same biovar of Psa (biovar 3) (Chapman et al., 2012; Vanneste et al., 2013). During the 2 years that the pathogen has been present in New Zealand, over 60% of the area planted in kiwifruit has been affected (Kiwifruit Vine Health, 2012). This rapid spread may be attributable to the virulence of biovar 3 and to the scarcity of products available for control of plant pathogenic bacteria in general, and Psa in particular. Many products used for control of plant pathogenic bacteria contain antibiotics (mostly streptomycin) or heavy metals (mostly copper). Both types of products do have limitations because of phytotoxicity or because they are not authorized in some countries (e.g., antibiotics in Europe). This has led to a large screening programme in New Zealand for the identification of potentially effective products to control Psa. The products tested included a number of commercially available potential elicitors of host resistance. One of the most effective elicitors in glasshouse trials on A. chinensis and A. deliciosa was acibenzolar-S-methyl [ASM], sold under the names of Bion® or Actigard® (Syngenta).File | Dimensione | Formato | |
---|---|---|---|
fpls-04-00024.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
783.94 kB
Formato
Adobe PDF
|
783.94 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.